1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial

Benjamin Besse, Julien Adam, Nathalie Cozic, N. Chaput-Gras, David Planchard, Laura Mezquita, J. Remon Masip, Pernelle Lavaud, Charles Naltet, Anas Gazzah, Vincent de Montpréville, Maria‐Rosa Ghigna, Sacha Mussot, Élie Fadel, Laurence Mabille, Boris Duchemann, Fabrice Barlési, J.C. Soria, Caroline Caramella, Olaf Mercier